Park Ha Biological Technology shares drop 62.91% intraday after reporting a 94.14% quarterly decline in EPS and significant profit decline.

Park Ha Biological Technology Co., Ltd. plunged 62.91% intraday, as the company's latest financial data showed a 94.14% quarterly decline in EPS, indicating a significant deterioration in profitability. Despite a 40.59% increase in sales, profits have severely declined, reflecting operational difficulties. Analysts reported on March 31, 2025, that the company faces challenges in maintaining sustainable growth and profitability, with high valuation metrics such as a P/E ratio of 19.08 and a P/S ratio of 12.24.